Duosone (3 mg+3 mg)/ml is a Product of the Generic Betamethasone Sodium Phosphate + Betamethasone Acetate

What Is Duosone (3 mg+3 mg)/ml Indications and Uses?

Bone and Joint disorders : Osteoarthritis, Rheumatic disorders (e.g Rheumatoid arthritis including juvenile rheumatoid arthritis, Acute gouty Arthritis, Acute rheumatic carditis, ankylosing spondylitis, psoriatic arthritis Dermatologic conditions : Psoriatic ... Read more Bone and Joint disorders : Osteoarthritis, Rheumatic disorders (e.g Rheumatoid arthritis including juvenile rheumatoid arthritis, Acute gouty Arthritis, Acute rheumatic carditis, ankylosing spondylitis, psoriatic arthritis Dermatologic conditions : Psoriatic Plaques, Alopecia areata, Stevens-Johnson syndrome, Discoid lupus erythematosus, Keloids Allergic conditions : Asthma, Atopic dermatitis, Contact dermatitis, Drug hypersensitivity reactions, Transfusion reaction Localized Inflammatory Issues : Bursitis, Tenosynovitis, Epicondylitis Respiratory conditions : General respiratory conditions responsive to corticosteroids e.g. bronchial asthma, hay fever, allergic bronchitis. Neoplastic diseases : Palliative management of leukemias and lymphomas.

Pharmacology (Source, Chemical and Physical Composition) Of Duosone (3 mg+3 mg)/ml

Duosone (3 mg+3 mg)/ml (Betamethasone Sodium Phosphate + Betamethasone Acetate) and Betamethasone Acetate Injectable Suspension is a sterile, aqueous glucocorticoid formulation with potent anti-inflammatory and immunosuppressive properties. It contains two esters of betamethasone that provide dual-phase activity: Betamethasone Sodium Phosphate: A highly water soluble ester ensuring rapid onset of action. Betamethasone Acetate: A low-solubility ester offering prolonged therapeutic effect. This combination is effective in the management of various corticosteroid-responsive conditions affecting multiple organ systems, including musculoskeletal, dermatologic, allergic, respiratory, gastrointestinal, and hematologic disorders.

Dosage And Administration of Duosone (3 mg+3 mg)/ml

Indication Route Dose Frequency Notes Rheumatoid Disorders, Osteoarthritis Intra-articular 0.5-2 mL Very large joints: 1-2mL Large: 1 mL Medium: 0.5-1 mL Small: 0.25-0.5mL At intervals of every 1-4 weeks based on individual patients' response Relief within 2-4 hours, no secondary flare reported. Bursitis, Tenosynovitis, Peritendinitis Intra-articular, Intrabursal 0.5-1 mL At intervals of every 1-2 weeks, once or repeated as needed (up to 3-4 injections) Typically restore full range of movement within hours. Injection should be made into the affected tendon sheaths, not tendon. Acute gouty arthritis Intra-articular 0.5-1 mL At intervals of 3 days to a week based on individual patients' response Monitoring of response is needed Dermatologic lesions Intralesional 0.2 ml of injection per cm² of lesion, not more than 1 ml per site At weekly intervals based on individual patients' response Injection should be made using a tuberculin syringe with a 25-gauge, ½-inch needle Allergic and Respiratory conditions Intramuscular 1-2 mL At weekly intervals based on individual patients' response Systemic anti-inflammatory effect Acute exacerbation of multiple sclerosis Intramuscular 5 mL/day for 1 week, followed by 2 mL every other day 1 month Taper based on response; short-term high-dose therapy Neoplastic disorder Intramuscular 0.25-9mg per day, based on individual patients' response As required The dose may be adjusted downward over time to the lowest effective level. Children : Usual dose 0.02-0.3 mg/kg daily in 3 or 4 divided doses. Dosages is individualized according to the disease being treated and patient response. Co-administration with Local Anesthetic : Duosone (3 mg+3 mg)/ml (Betamethasone Sodium Phosphate + Betamethasone Acetate) and Betamethasone Acetate Injectable Suspension can be mixed with 1% or 2% lidocaine HCl. First, withdraw the required suspension dose into the syringe, then add lidocaine and shake briefly. Do not inject lidocaine into the suspension vial.

Drug Interactions of Duosone (3 mg+3 mg)/ml

Duosone (3 mg+3 mg)/ml (Betamethasone Sodium Phosphate + Betamethasone Acetate) + Betamethasone acetate injectable suspension has notable drug-drug interactions that require careful monitoring. Hepatic enzyme inducers such as phenytoin, carbamazepine, rifampin, and barbiturates can accelerate its metabolism and reduce efficacy, while CYP3A4 inhibitors like ketoconazole, itraconazole, ritonavir, or cobicistat can increase corticosteroid exposure and adverse effects. Estrogens, including oral contraceptives, may potentiate its effects. Concurrent use with potassium-depleting agents (e.g., loop diuretics, amphotericin B) heightens hypokalemia risk. NSAIDs and aspirin may increase gastrointestinal ulcer or bleeding risk, and oral anticoagulants (e.g., warfarin) may have variable effects, necessitating coagulation monitoring. Corticosteroids can elevate blood glucose, reducing the efficacy of antidiabetic agents, and co-administration with cyclosporine may enhance drug activity and provoke seizures. Cholestyramine can increase corticosteroid clearance, while some macrolides may decrease clearance, altering exposure. These interactions can be clinically significant, so all concomitant medications should be reviewed before use.

Side Effects of Duosone (3 mg+3 mg)/ml

Local : Pain, redness, or infection at the injection site Systemic (with prolonged use or high dose) : Cushingoid features (e.g., moon face, weight gain), Hyperglycemia, Hypertension, Mood or behavioral changes, Osteoporosis, Increased risk of infection, Adrenal suppression

Precautions And Warnings for Duosone (3 mg+3 mg)/ml

Use caution in patients with diabetes, hypertension, osteoporosis, or peptic ulcer May cause adrenal suppression with prolonged use Avoid live vaccines during treatment Risk of infection at injection site May mask signs of infection Not for IV administration Shake well before use

Use During Pregnancy and Lactation

Pregnancy : Category C. Duosone (3 mg+3 mg)/ml (Betamethasone Sodium Phosphate + Betamethasone Acetate) and Betamethasone Acetate Injection should be used during pregnancy if the possible benefits of the medication justify the potential hazards to the fetus. Lactation : Betamethasone Sodium Phosphate and Betamethasone Acetate may appear in human milk and could suppress growth. Caution should be exercised when Betamethasone Sodium Phosphate and Betamethasone Acetate is administered to a nursing mother.

Therapeutic Class

Corticosteroid

Storage Conditions of It

Store below 30°C. Protect from light. Do not freeze. Keep out of reach of children. Shake well before use. Pack Images: Duosone (3 mg Injection Thanks for using MedEx! How would you rate your experience so far?